Nitroglycerin NDC 51662-1340

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1340Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1340Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1340-1	51662134001	30 g in 1 TUBE (51662-1340-1)Marketed from Dec 22, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nitroglycerin
Generic name (nonproprietary): nitroglycerin
Active ingredients: Nitroglycerin — 20 mg/g
Dosage form: Ointment
Route: Topical
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 087355
Marketing start: Dec 22, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Nitrates (Chemical structure)Vasodilation (Physiologic effect)
Identifiers: Product ID 51662-1340_ef6d3da2-6bf9-fbc7-e053-2a95a90a74cdSPL ID ef6d3da2-6bf9-fbc7-e053-2a95a90a74cdSPL set ID 7da79fdf-0969-1ddd-e053-2991aa0a3ec4RxCUI 242946UNII G59M7S0WS3
Pharmacologic class: Nitrate Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451662134001 followed by a unit qualifier and the quantity

Package 51662-1340-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 9, 2022.

Indications (excerpt from the label)

INDICATIONS & USAGE Nitroglycerin ointment is indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 087355

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 087355
Product	Strength	Form · route	Labeler	Product NDC
Nitro-Bidnitroglycerin	Nitroglycerin 20 mg/g	OintmentTopical	Savage Laboratories a division of Fougera Pharmaceuticals, LLC	0281-0326